Screening Flashcards

1
Q

MSS1
When can it be done
When is it best done
What does it involve

A
Bloods
Best 10 weeks (possible 9-13+6)
Hcg
PAPP-A
NT scan
Best 12 (possible 11+2-13+6)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MSS 2
When can it be done
When is it best done
What does it involve

A
Bloods only + age weight and gestation 
14-20 weeks (best 14-18) 
Bhcg
unconjugated oestradiol
AFP
Inhibin A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the booking bloods

A
FBC 
Group and screen
Iron studies 
Rubella
Hep B
HIV 
Syphillis
MSU - Asymptomatic bacteriuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cystic fibrosis

What is it
What is the pathology

A

An autosomal recessive genetic disease of the exocrine
glands. Cystic fibrosis is characterised by epithelial secretory dysfunction associated with ductal obstruction resulting in airway obstruction; chronic respiratory infections; pancreatic insufficiency; maldigestion; salt depletion; and heat prostration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is fetal Cell free DNA

- NIPT

A

Cell-free fetal DNA of placental origin is detectable in maternal plasma from early first trimester.
Screening test - T21, T18 Edward syndrome and T13 Patau syndrome.
These cell-free fetal DNA fragments are released and
comprise about 10% of the total cell-free DNA in maternal blood.
CfDNA testing for fetal aneuploidy works by sequencing a portion of each DNA fragment in maternal plasma (both maternal and fetal), mapping each DNA sequence to a reference genome to determine its chromosome of origin, and counting the number of fragments arising from each chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T21

What are the manifestations

A

hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe intellectual disability. Cardiac and
gastrointestinal malformations, a marked increase in the incidence of leukemia, and the early onset of Alzheimers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fragile X chromosome
What is it
What are the manifestations
Who do you screen

A

intellectual disability, behavioural and learning challenges and various physical characteristics.
Caused by the expansion or lengthening of the FMR1 gene on the X chromosome, known as a gene mutation.
When the gene lengthens it switches off production of a protein that is involved in brain development and other functions. It is also the most common single gene cause of autism worldwide.(no ethnic correlation)
Only women need be offered FXS screening. FXS screening is particularly important if there is a family history of intellectual disability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a MoM

Multiple of median

A

A multiple of the median (MoM) is a measure of how far an individual test result deviates from the median. MoM is commonly used to report the results of medical screening tests, particularly where the results of the individual tests are highly variable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a Negative predictive value

A

The negative predictive value is the proportion of negative results in tests that are true negative results. The NPV is not intrinsic to the test—it depends also on the prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a positive predictive value

A

The positive predictive value is the proportion of positive results in tests that are true positive results. The PPV is not intrinsic to the test—it depends also on the prevalence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Turners syndrome

A
A syndrome of defective gonadal development in
phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with
undifferentiated gonads (streak gonads), sexual infantilism, hypogonadism, webbing of the neck, cubitus valgus, elevated gonadotropins, decreased estradiol level in blood, and congenital heart defects.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Folate deficiency

causes and presentation

A
Macrocytic anaemia (raised 25% pregnancies) 
Raised MCV also check for drugs eg azathioprine and EtOH
At risk of folate deficiency include woman on anticonvulsants or folate antagonists (sulphasalazine) or haematological conditions eg haemolytic anaemia, sickle cell, thalassaemia, hereditary spherocytosis (prescribe 5mg daily)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

routine Iron supplementation

A

Routine supplementation no benefit and ? increase perinatal death, SA constipation, diarrhoea and nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rubella infection in pregnancy
Epidemiology
When is it significant / what is the risk of fetal transmission

A

1-2 % of woman are not immune - the risk of them contracting Rubella infection in pregnancy is 2/1000

Highest risk in the first 16 weeks
Risk of transmission
<11 weeks 90% (90% of these pregnancies will be affected badly)
11-16 weeks 55% (20% risk of severe complications)
16+ 45% risk of transmission
16-20 weeks risk of deafness only
20+ risk no increased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rubella transmission and sx

A

Transmission 10 days before the rash to 15 days after sx onset
1-5 day prodromal illness then rash 3-5 days. Rash face + neck to trunk and extremities Petechiae on soft palate that coalesce to papules - forschheimers sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fetal consequence of rubella infection

+ diagnosis

A

microcephaly, IUGR, meningoencephalitis, cataracts, retinopathy, hearing loss, cardiac defects, hepatosplenomegly, thrombocytopenia w purpura, bone radiolucencies,
bluish red skin, adenopathy interstitual pneumonia
developmental delay
Dx- serology, viral culture of amniotic fluid, Fetal blood sample

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

GBS screening

Who to treat in labour

A

20% woman colonised
Not routine screening
In labour treat PTB, PROM >18 hours, Intrapartum fever, or previous GBS baby
If previous GBS in urine then retest at 36 weeks - if positive then treat GBS in labour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How commonly do soft markers occur

What is the negatives about reporting them?

A

11-17% of the population
higher prevalence in aneuploid fetuses and the likelihood of aneuploidy is significantly increased when more than one marker is present.
Inefficient for screening, a detailed evaluation of fetal anatomy should be performed whenever one or more soft markers has been identified.

information is anxiety-provoking for patients, requires considerable time for counseling, and may lead to invasive prenatal testing. Such testing may result in procedure-related loss of a normal fetus, and is costly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the significance of an Absent nasal bone

A

0.8% normal population
65% T21
The optimum time for nasal bone assessment is at crown rump length of 65 to 74 mm (13 to 13.5 weeks of gestation)
When the fetal profile is viewed in the midsagittal plane, the nasal bone synostosis appears as a thin echogenic line within the bridge of the nose. The nasal bone is considered present if this line is more echogenic than the overlying skin, and absent if it is not visualized, or less echogenic, than the overlying skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are are associations with Echogenic bowel?

A

1-2% of the normal population
13-21% of T21
Fetal echogenic bowel refers to increased echogenicity (brightness) of the fetal bowel noted on second trimester sonographic examination
Also been associated with this finding: other chromosomal defects, fetal growth restriction, cystic fibrosis, congenital infection, intraamniotic bleeding, and gastrointestinal obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is Pyelectasis

A

1-3% normal population
10-25% T21
Pyelectasis or mild hydronephrosis is a common finding in fetuses. Studies that defined pyelectasis as renal pelvic diameter of ≥4 mm at 15 to 19 weeks of gestation demonstrated pyelectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Shortened long bones (humerus, femur)

Concerns? Significance?

A

Fetuses with Down syndrome have slightly shorter long-bones than their normal counterparts. A shortened humerus appears to be a better predictor of Down syndrome than a shortened femur (positive likelihood ratio 4.8 and 3.7, respectively)
Various criteria have been published for determining whether a femur or humerus is too short
These criteria overlap the range observed in unaffected fetuses and vary widely among different populations; therefore, each laboratory should develop specific standards for its own population. We consider abnormal an observed-to-expected length ratio (based on biparietal diameter) of less than 0.9.
In contrast, severely shortened (<5th percentile) or abnormal appearing long bones may be a sign of a skeletal dysplasia or early onset fetal growth restriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is a Echogenic intracardiac focus
What rate in normal population?
What rate in T21

A

Normal 3-5%
28% in T21

Echogenic intracardiac foci, the same brightness as bone, usually occur as a single focus in the left ventricle, but multiple foci, biventricular foci, or a right ventricular location can also occur. This entity is different from diffuse, extensive myocardial calcification, which is rare and associated with myocardial dysfunction
The incidence varies across races/ethnicities (present in up to 30 percent of Asian fetuses), and decreases with advancing gestational age It is thought to be related to microcalcification and fibrosis of the papillary muscle or chordae, often disappears later in pregnancy or postnatally, and is not associated with myocardial dysfunction or structural anomalies. In an autopsy study of abortuses, stillbirths, and perinatal deaths, discrete central papillary muscle calcification was more common in fetuses with trisomy 13 than trisomy 21 (39 and 16 percent, respectively, versus 2 percent of normal controls)
When an echogenic intracardiac focus is identified in an otherwise normal second trimester fetus, a normal cell-free DNA test can be very reassuring and obviate the need for invasive testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is a Choroid plexus cyst

What other feature makes T18 much less likely?

What is the risk of aneuploidy vs the risk of amnio

A

Choroid plexus cysts are most common in the second trimester.
They appear to result from filling of the neuroepithelial folds with cerebrospinal fluid The typical sonographic appearance is a small (usually less than 1 cm), sonolucent structure(s) with well delineated borders located within the choroid plexus. A wide range of appearances are possible from unilateral single cysts to bilateral septated and multiple cysts. A targeted scan for other fetal anomalies should follow imaging of these cysts.
In addition, if the fetus is able to unclench its hand and hold it open, trisomy 18 is not likely. In a meta-analysis including 748 fetuses with isolated choroid plexus cyst(s), the risk of trisomy 18 was 1/374 and the positive predictive value was 1/390
When isolated choroid plexus cyst(s) are detected in an otherwise low risk patient the risk of amniocentesis (1/250 chance of pregnancy loss) is higher than the risk that the fetus has trisomy 18 (less than 1/374). We suggested restricting amniocentesis to patients with additional sonographic abnormalities or high risk factors (ie, advanced maternal age [older than 32 years at delivery [62]], abnormal serum analyte screen) [63]. Some women may request amniocentesis after risk-benefit counseling. When choroid plexus cysts are identified in an otherwise normal second-trimester fetus, a normal cell-free DNA test can be very reassuring and obviate the need for invasive testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Single umbilical artery

How to interpret?

A

There is a well-documented association between single umbilical artery (SUA) and an increased risk of aneuploidy when additional fetal malformations are detected. The rate of aneuploidy with isolated SUA is not known, but most experts do not recommend routine chromosomal analysis if there are no other malformations or other indications for genetic amniocentesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is a Cystic hygroma

A

A cystic hygroma is a thin-walled, subcutaneous uni- or multilocular subcutaneous mass filled with lymphatic fluid and usually occurring in the posterior neck. It results from a localized area of lymphatic dysplasia with dilatation and/or leakage of lymph from the lymphatic vessels. It may be accompanied by generalized lymphedema. A small, unilocular cystic hygroma without accompanying diffuse lymphedema may be difficult to distinguish from other causes of nuchal thickening. By comparison, septations are characteristic of multilocular cystic hygromas and readily differentiate cystic hygromas from simple increased nuchal translucency.
First trimester cystic hygromas are often associated with trisomies, whereas second trimester cystic hygromas are often associated with monosomy X.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How to interpret

ventriculomegaly

A

Isolated ventriculomegaly is a risk factor for Down syndrome, but most children with isolated, mild ventriculomegaly have a normal outcome.
Mild ventriculomegaly is detected in 4 to 13 percent of fetuses with Down syndrome and 0.1 to 0.4 percent of euploid fetuses
The risk of abnormal outcome, such as Down syndrome, increases with the degree of ventriculomegaly, progression of ventriculomegaly, and presence of other anomalies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Second trimester nuchal fold

A

0.5-2% normal pregnancies
20-33% T21
The nuchal fold, rather than nuchal translucency, is measured in the second trimester. The nuchal fold is the measurement between the outer edge of the occipital bone to the outer margin of the skin and is taken in the axial plane. An increase in this measurement is also associated with aneuploidy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Omphalocele

Risk
Mortality
Associated chromosomal abnormalities

A

• 1:4000 births
• 25% mortality
• 15% chromosomal abnormalities
• 30% have other congential abnormalities
• 60% of omphaloceles not containing liver are associated with fetal aneuploidy esp T18 T 13
• THe more other abnormalities the higher risk of a chromosomal disorder
• Most common chromosomal abnormalities
T18 63%
T13 17%
T21 4%
Turners 6%
Triploidy 5%
Rare chromosomal deletions 5%
• Associated structural abnormalities in 35-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the prevalence of NTD

When does it occur

What is the pathophysiology?

A

5-10 / 10 000
Note defects occur week 5-6 of gestation
(which is 3-4 weeks post fertilization)
When the neural folds of ectoderm closes
The neural tube develops into brain, spinal cord and meninges
The mesoderm form the vertebral structures over the neural tube
Failure of the neural tube to form means the mesoderm does not organise around it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is spina bifida?

What does it mean if it is open?
closed?

A

Spina Bifida - the neural tube does not completely close - can be open or closed

Open - not covered by skin - 80% - associated with ventriculomegly

Closed - covered by skin - 20% - is covered by skin, can have a hairy patch
(eg lipomenigocoele, lipomyelomeningocoele)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q
Types of NTD
What do they mean? 
Occultia?
Meningocele?
Myelomeningocoele? 
anencephaly?
Craniorachiachisis ?
A

occultia - small gap but no opening, nerves or spinal cord not damaged. Often asymptomatic - may have hair, dimple or birth mark over the lesion.
Meningocele - sac of meninges protruding (not the nerves) least common, often spinal cord is ok.
Myelomeningocoele - most severe - open or closed, bones form incompletely - meninges and spinal cord bulging out. Can damage exposed nerves -loss of power and sensation distally, no bladder or bowel control MSK deformities, seizures. Associated with arnold chiari II malformation where cerebellar and brain stem slips down into the foramen magnum. This results in hydrocephaly. Dx often antenatal (high AFP as leaks from fetus into amniotic fluid and maternal blood stream)

Anencephaly - The neural tube fails to close cranially,

Completely unfused - craniorachiachisis

33
Q

What are the risk factors for NTD?

A

90% of patients have no risk factors
Folic acid deficiency
Dietary deficiency
Inadequate absorption - IBS, intestinal resection, celiac, liver diease
Folic acid antagonists eg carbapezapine, valproic acid, MTX also trimethprim, sulphasalazine
MTHFR is an enzyme that regulates intracellular folate levels - a genetic polymorphism reduces its activity and therefore increases their risk of NTD
Appears to be a genetic component although no gene yet isolated

Previous pregnancy with NTD (10X risk - 70% risk reduction)
Either parent with a personal hx (10X risk)
Family Hx if a second or third degree relative is affected (risk .5 to 1%)
Antiepileptic drugs - consult neurologist as can affect antiepileptic action
Diabetes - mixed recommendations
Obesity 2X increased risk
Poorly controlled diabetes
Twins
? associations with pesticide exposure, HIV drugs, clomiphine

34
Q

What supplementation reduces the risk of NTD

A

Supplementation reduces NTD by 93%
Some bodies say that all woman with child bearing potential take folic acid supplementation due to the high rate of unplanned pregnancy
0.4mg OD from 1 month before conception
Population based fortification in flour of cereals/bread / rice / pasta reduces NTD

High dose prophylaxis
High risk are candidates for higher dose 1-4 mg daily
from 3/12 before conception + continue for the first 12 weeks after which reduce the dose to 0.4mg

Previous pregnancy with NTD (10X risk - 70% risk reduction)
Either parent with a personal hx (10X risk)
Family Hx if a second or third degree relative is affected (risk .5 to 1%)
Antiepileptic drugs - consult neurologist as can affect antiepileptic action
Diabetes - mixed recommendations
Not recommended for obesity

35
Q

What syndromes are related to NTD ?

A

Associated syndromes eg T13 T 18 triploidy, meckel - gruber, Roberts HARD, amniotic bands

36
Q

Fever in T1 increases the risk of what?

A

Elevation of maternal temperature in T1 (spa baths, fever) increases the risk of NTD, CHD and oral clefts

37
Q

When can NTD be detected?

A

12-14 week USS will detect 90% anencephaly, 80% encephalocele, and 44% spina bidifa
20 week USS - 100% anencephaly and 95% spina bifida
Obesity decreases detection rates

38
Q

AFP
What does it do
What is the pattern through pregnancy
What is its value?

A

Fetal specific globulin, synthesised in the fetal yolk sac GI tract and liver
unknown function
Can be measured in the maternal serum, amniotic fluid or fetal plasma
Rises in early pregnancy, peaks at 28-32 weeks then falls - the maternal serum level rises in advancing gestations likely because the increased fetoplacental permeability

Secreted by the fetal kidney into the urine then into the AF - in the amniotic fluid it peaks 12-14 weeks then declines and becomes undetectable at term

Measurements in the amniotic fluid may aid NTD diagnosis
AFP peaks in fetal plasma 10-13 weeks then declines
Best timing screening maternal serum AFP 16-18 weeks (15-20)
Results are MoM for each gestational week, abnormal is over 2 or 2.5 MoM
Ancencephaly over 95% detection FP 2-5% , SB 75-90%, false positives 1-3%

2009 metaanalysis 700000 woman Sensitivity 75% specificity 98% false positive 2.2% false negative 25%

39
Q

What affects AFP interpretation?

A

Gestational age (levels change throughout)

Maternal weight - dilutional if high BMI

T 1 and2 DM - The level of MS AFP is lower in diabetics so they need a lower cut off

Also raised if abdo well defects, anaemia, nephrosis, teratomas, uropathy evelates AFP

Twins elevates

Normal levels higher in black woman - MoM should be adjusted

Viability - fetal death raises MSAFP

low in T21 and T18

40
Q

Unexplained AFP - what does it increase the risk for?

A

early fetal demise
IUGR
PET
No evidence that intensive fetal monitoring will improve outcome

41
Q

After dx NTD what other fetal assessment needs to occur?

A

Fetal assessment after diagnosis
20% have associated abnormalities
Cleft palate
MSK renal and cardiovascular malformations

Chromosomal microarray
6% chromosomal abnormalities - often if multiple abnormalities
Microarray is preferred if structural abnormalities
Appropriate if will change management

Fetal MRI
Confirm uncertain findings
Help assess CNS abnormalities

42
Q

If delivery of a baby with NTD
What are the considerations?
MOD?
Equipment?

A

Levels 3 paeds / paeds neurosurg
Latex free gloves + equipment - associated with life threatening latex allergy
Term is better
Breech - for LSCS
If cephalic no good evidence about MOD - if head is near normal size then meningocoele unlikely to cause dystocia

LSCS if HC over 40 cm or BPD more then 12 cm

43
Q

Other postnatal considerations for a NTD baby?

A

Post Natal

Work up for renal involvement - Check urinary tract function, U+Es
Look for hydropcephaly may need a shunt
Neurogenic bladder - tx anticholinergics
ADHD
Weight gain
Faecal and urianry incontiencne
UTI
Hydrobephrotos - VUR
Sexual dysfunction
Orthopaedic abnormalitiy

44
Q

Recurrence NTD

A

Risk of recurrence is 2-4% if one affected sibling
2 affected siblings risk is 10%
Anencepahly recurrence 2-5%
Testing for MTHFR not recommended as can treat with folic acid supplementation

45
Q

What is the most common abnormality that causes miscarriage?

A

18% is Monosomy X (turners)

75% of cases paternal X missing

46
Q

What does aneuploidy mean?

A

Any deviation from the diploid 46 chromosomes

principal cause is non disjunction during cell division
99% embryos lacking a chromosome abort spontenously

47
Q

Trisomy

Waht is the incidence of the main trisomy conditons?

A

Three chromosomes of one type
This is caused by meiotic non disjunction of chromosomes
Risk associated with increased age

T21 1:800
18 1:8000
13 1:25,000

48
Q

What does mosaicism mean?

A

2 cell lines with 2 or more different genotype
either autosomes or the sex chromosomes involved

Less serious birth defects (then monosomy or trisomy)

Result of non dysjunction in early cleavage of the zygote
Loss of chromosomes by anaphase lagging - the chromosomes separate normally but then one of them is delayed and lost

49
Q

What are structural chromosomal abnormalities ?

A

These are a result of chromosome breakage
This is caused by environmental factors eg irradiation, drugs, chemicals, viruses
These can be translocations or deletions

50
Q

How do we clinically screen for risk of PET?

A

Past personal or family Hx
Medical disorders eg HTN, renal disease or diabetes
Current pregnancy factors eg multiple pregnancy
Assess BP BMI

51
Q

What about biochemical screening for PET?

A

RANZCOG says there is not enough evidence

Data is distorted by including multips who already have high postive predictive value with their own PET hx - improving the dataset outcomes

They include PAPP-A, PIGF (placental growth factor) and uterine artery PI

There is a 10% false positive rate
90-95% sensitivity
- for a disease prevalence 3-4:1000
results not replicated

only for early onset PET
not at all effective with late PET (which is 2/3 of PET)

52
Q

FGR

Long term and short term affects on the fetus

A

Short term
Being growth restricted is implicated in half of stillbirths.
Perinatal mortality increases with decreasing birth weight centile, with the adjusted perinatal mortality 3 times higher with a birth weight of <5-10th centile and nearly 15 times higher when birth weight is <1st centile.

Implicated in Childhood morbidity, and of disease in adult life (obesity, type 2 diabetes and cardiovascular disease).

53
Q

What are risk factors for SGA?

Major risk factor- serial USS and umbilical artery doppler for wellbeing

3X minor then uterine artery doppler at 20 weeks and make a plan for serial scans from there
- if normal then consider 1X scan in T3
If +ve then serial growth scans

A
These major risk factors include 
previous small for gestational age infants, 
previous fetal death in-utero, 
current pre-eclampsia, 
current significant unexplained antepartum haemorrhage, 
diabetes mellitus with vascular disease, 
renal impairment, 
antiphospholipid antibody syndrome, 
systemic lupus
erythematosis, 
smoking ≥ 11 cigarettes a day, 
daily vigorous exercise 
maternal age >40

The RCOG guidelines also suggest that women with three or more minor risk factors,
including previous pre-eclampsia,
maternal age ≥35 years,
daily vigorous exercise,
BMI <20 or >35kg/m2
should be referred for a uterine artery Doppler at 20-24 weeks, and further ultrasound
surveillance should be determined according to the normalcy of this uterine artery Doppler

54
Q

What biochemical marker is linked to FGR

A

Although low pregnancyassociated plasma protein A (PAPP-A) <5th centile at time of nuchal translucency screening (<0.4 MoM) has been found to be associated with an increased risk of SGA, the odds ratio (OR) for SGA infant (birth weight <10th centile) and severe SGA (birth weight <3rd centile were 2.7 and 3.7,
respectively with the detection rate of SGA being poor at 12% and 16%, respectively

A metaanalysis found that the most accurate predictor for birth weight < 10th centile was PAPP-A <1st
centile (0.3MOM); LR+ 3.50 (2.53,4.82), LR- 0.98 (0.97,0.99). For birth weight <5th centile, the
most accurate predictor was again PAPP-A <1st centile; LR+ 4.36 (3.27,5.80), LR- 0.97
(0.96,0.98).

55
Q

Prepregnancy screening
History and examination
Clinical examination?

A

History
Medical problems, optimise,
Medications - ensure safe medication in pregnancy
Mental health status

FHx
Genetic inheritable conditions
High risk - referral to genetic counselling
low risk - should be made aware of the availability of carrier status evaluation (not funded)

Vaccinations
check immunity to Hep B rubella and varicella and vaccination if appropriate
In pregnancy dTAp 28-32 weeks and influenza

Examination
BP BMI Heart sounds, if relevant breast exam and cervical smear

56
Q

Prepreg consult - what are the lifestyle recommendations

A

Balanced diet
BMI (affects fertility, health of the oocyte and embryo quality - linked to still birth, miscarriage and anomaly)
Moderate intensity exercise
Excessive caffeine >300 mg/ day (3-4 cups) should be avoided

Folic acid
Minimum 1 month pre preg for first 12 weeks of pregnancy
0.8mg if no risk factors
5mg (High BMI diabetic, Prev NTD or FHx, AED)

Iodine 150 mcg prior to planned pregnancy/ ASAP and throughout pregnancy and breastfeeding
Stop smoking and drinking

Travel
avoid travel to affected areas
If travelling to a zika infected country prevent mosquito bites, use condoms while having sex in that country

Dont live somewhere with exposure to toxins or radiation

57
Q

How to counsel for diagnostic testing

A

a. A description of the conditions that can and cannot be detected through traditional
screening processes and details of the testing process. This should include information
about phenotypic variability of chromosomal conditions and the difficulties in being
able to predict the extent of effect on a particular baby.

b. A discussion of the differences between screening and diagnostic tests.

c. Advantages and disadvantages of the different types of tests available (taking into
account the gestation of the pregnancy).

d. Practical aspects of testing; including the timing of tests and the approximate costs
involved.

e. The possibility that the screening and diagnostic pathway may reveal anomalies other
than those expected.

f. Details of support groups and sources of further information (see How to decide on
antenatal tests for chromosomal abnormalities and other conditions and Antenatal
screening for Down syndrome and other conditions (New Zealand).

g. The understanding that, if a chromosome or genetic condition is diagnosed, a woman
can choose whether to continue or terminate the pregnancy. Where a condition has been diagnosed, parents should be given sufficient information regarding the aetiology, associations, and implications of that diagnosis during pregnancy, the newborn period and beyond, in order to make informed decisions about their options.

58
Q

What is the biggest risk factor for T21 ?

A

The most important factor for
having a child with trisomy 21 is maternal age. The chance of an affected newborn at term is
approximately 1 in 300 for a woman aged 35 years, increasing to 1 in 100 by the maternal age of 40
years.7 The overall prenatal prevalence of trisomy 21 has increased with the trend to later childbearing
in many developed countries

59
Q

What is the commonly detected abnormality?

A

Trisomy 21 comprises approximately half of the chromosome abnormalities detected prenatally. The
next most common autosomal trisomies are trisomy 18 and trisomy 13. Together, trisomies 21, 18 and
13 make up about 66% of major aneuploidies currently detected by prenatal diagnosis

60
Q

When can cell-free DNA testing be performed?

A

From 10 weeks

If have cellfree DNA testing they should still have an USS for structural assessment

until 15-20 weeks

61
Q
T21 screening
Options
Gestations
Sensitivity
Specificity
PPV
A

CFTS 11-13+6
Sensitivity 85% specificity 95% PPV 10%

Second trimester screen 14-20 weeks
Sensitive 7-% specificity 93%
PPV 2-3%

cfDNA after 10 weeks
99% sensitivity and specificity
45% PPV

62
Q

cfDNA
Failure?
if repeated?

A

1-5% no result

if repeated 50% have a result

63
Q

What are other USS findings that can contribute to aneuploidy detection in T1

A

tricuspid valve flow
nasal bone
ductus venosus waveform

improve detection but te

64
Q

How to screen multiples?

A

Twins
ALL USS 11-13 weeks for chorionicity, morphology + nuchal
CFTS - less accurate 72-80% - nasal bone included helps increase to 90%

labs need to know - gestation, chorioicity, demise, CRL of both

Can do second trimester screen

Can do cfDNA- higher no call rate, less data to back it

Triplets - USS +/- nasal bone

65
Q

invasive testing
When
loss rate

CVS

Amnio

A

loss rate 1:900
depends on experience

It is acceptable to go straight for invasive testing if the woman has been fully counselled

Amnio
From 15 weeks (before 14 weeks increase the risk of talipes)

CVS
from 11 weeks

66
Q

What tests can be done on amnio sample?

A

Conventional karyotype
- cultured fetal cells to prepare stained metaphase chromosome for microscopic inspection

FISH - rapid aneuploidy test - rapid assessment of common abnormalities T21,18,13, sex chromosome abnormalities as well as specific gene deletions eg giGeorge

Chromosomal microarray - Genome wide oligonucleotide array - detects large and small deletions (they do not detect balanced translocations or single gene disorders)
This is best if there are structural abnormalities
microarray detect variants
of uncertain or unknown significance in about 5%

67
Q

genetic carrier screening

who is it for?

A

low risk people
It is estimated that all individuals are carriers for at least three clinically severe recessive childhood
disorders.
Most of these are autosomal.

24% of adults with test postiive for at least one recessive disorder on expanded carrier testing

68
Q

What is the ethnicity increases the risk of different genetic abnormalities?
CF
Tay sachs
Thalassaemia

A

CF - Northern european and Ashkenazi jews

South East asians - thalassaemia

Tay Sachs - Ashkenazi Jews

69
Q

What are the options for genetic testing pre pregnancy?

What methods are possible?

A

One step testing

  • same time
  • run results for each person

Two step
= cheaper
- test female, then only test male for what she is a carrier for
- takes longer

70
Q

How does ART affect CFTS

A

ART results in T1 in low PAPPA - more likely to have a false positive result in CFTS

Higher rate of cfDNA failure 5.2 % vs 2.2%

71
Q

how good is the nuchal for screening for major anomalies

A
detects 50% of major anomalies 
75 % of lethal abnormalities 
Most likely anencepahaly, abdominal wall defects 
megacystis
body stalk anomalies
72
Q

what doppler should you not use in T1 ?

A

Pulsed Doppler ultrasound should not be used routinely in first trimester.
If pulsed doppler examination is necessary, the Thermal Index should be <1.0 and
exposure time minimised (ideally to 5-10 minutes).

73
Q

incidence of major structural anomaly

A

2-3%

detection rates 60%

74
Q

What is the ALARA principle

A

the “ALARA” (“as low as reasonably
achievable”) principle - utilising the lowest amount of power exposure necessary to achieve the diagnostic purpose in
clinical practice. This entails using ultrasound only if there is an appropriate clinical indication, minimising exposure
time, using the lowest power and optimal gain settings to obtain the desired image, being mindful of operating
modes which increase the potential for bioeffects (e.g. power or pulse wave doppler) and being aware of the
Thermal Index (TI) and Mechanical Index (MI) on the ultrasound machine

75
Q

Is there harm from USS ?

A

It is widely accepted that ultrasound that induces a temperature rise in tissue of less than 1.5 degrees Celsius is not
associated with harmful sequelae. Some clinical situations entail an increased risk of inducing a temperature rise
beyond this limit and particular care must be taken when scanning febrile patients, fragile tissues of early gestation, poorly perfused tissues (e.g. eyes), or tissues with a high absorption co-efficient (e.g. bone). It is for this reason that pulsed Doppler should not be used routinely during the first trimester. If it is necessary, the TI should be <1.0 and
exposure time minimised (ideally to 5-10 minutes)

76
Q

If both members of a couple are known carriers of the same autosomal recessive
condition or a woman is a carrier of an X-linked condition, there are a number of options available
What are they?

A
  1. Having a child naturally and testing after birth to see if the child is affected.
  2. Conceiving naturally and having diagnostic testing during pregnancy to determine if the fetus is affected. This is usually performed with an invasive test (amniocentesis or chorionic villus sampling).
3. Conceiving the pregnancy by in vitro fertilisation (IVF) and testing embryos by preimplantation
genetic diagnosis (PGD). Unaffected embryos would then be selected for achieving pregnancy.
  1. Using donor sperm, egg or embryo from unaffected individuals.
  2. Adoption.
  3. Not having children
77
Q

People of (Ashkenazi) Jewish decent are more likely for what conditions?

A

Tay Sachs disease, Niemann Pick disease type A, Fanconi anaemia group C, familial
dysautonomia, Bloom syndrome, Canavan disease and mucolipidosis type IV

in addition to the normal Thalassaemia
CF
SMA
fragile X

78
Q

What is the incidence of being a carrier vs affected persons for
CF
SMA
Fragile X

A

CF
Carrier 1/35
Affected 1/5000

SMA
1/50 carrier
1/10 000 affected

Fragile X
Carrier 1/333
Affected 1/7000 males

chance of a single gene condition is 1/500